Research Article

Abnormal Movements of Japanese Infants following Treatment with Midazolam in a Neonatal Intensive Care Unit: Incidence and Risk Factors

Table 2

Characteristics of infants in the abnormal movement (+) group.

No SexAt birthAt the start of midazolam treatment Duration of midazolam administration (h) Birth asphyxia Intracranial hemorrhage
GA (weeks)Apgar score 1/5 minWeight (g)PNA (days)PCA (weeks)Weight (g)Dose (mg/kg/h)

(1)F27.05/7862027.08620.176.0+
(2)M25.14/57571627.48260.0942.0++
(3)M25.31/58142028.28140.096.0++++
(4)M30.43/71232130.612320.085.8+++++
(5)F30.7−/−1405130.913310.231.7+++
(6)M29.02/714513233.615240.100.1++
(7)F24.43/75598236.111080.201.5++
(8)F38.07/82580338.423060.210.7+
(9)F40.78/93773040.737730.131.0

GA, gestational age; PNA, postnatal age; PCA, postconceptional age.